4//SEC Filing
Parker Geoffrey M. 4
Accession 0001737287-25-000008
CIK 0001737287other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 8:15 PM ET
Size
6.7 KB
Accession
0001737287-25-000008
Insider Transaction Report
Form 4
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2025-01-24+173,913→ 1,305,901 total - Award
Stock Option (Right to buy)
2025-01-24+614,844→ 614,844 totalExercise: $1.94Exp: 2035-01-24→ Common Stock (614,844 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001491874
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 8:15 PM ET
- Size
- 6.7 KB